India’s pharma exports cross $28 bn till February, likely to end up with growth in rupee terms in FY26

Indias pharmaceutical exports have reached a milestone crossing $28 billion until February in the financial year 2026. This is an achievement that shows the strength of Indias pharmaceutical industry and the changing trends in global trade. The fact that exports are likely to grow in terms of the rupee even if they do not grow much in dollar terms adds another important aspect to this story. It highlights the connection between export performance, currency movements and economic conditions.

1. Overview of Indias Pharmaceutical Export Performance

Indias sector has continued to grow steadily in the financial year 2026. According to data exports have reached $28.29 billion from April to February in the financial year 2026. This represents a growth of 5-5.6% compared to the same period last year. The sector is expected to maintain its growth momentum until the end of the year 2026. This performance is notable because it comes despite economic slowdown, trade disruptions and pricing pressures in key markets. Indias pharmaceutical exports have remained strong despite these challenges.

2. Why the $28 Billion Milestone Matters

Crossing $28 billion is not a big number. It reflects the deeper strengths of Indias pharmaceutical industry. India is the largest pharmaceutical producer in the world by volume and is known as the “pharmacy of the world”. It supplies medicines to the world, especially generic drugs. India exports medicines to over 200 countries, including regulated markets like the United States and Europe. Than 60% of Indias pharmaceutical exports go to regulated markets, which indicates high-quality standards and compliance with strict regulatory norms.

3. Key Drivers of Growth in the Financial Year 2026

factors have contributed to the growth of Indias pharmaceutical exports. One key factor is the demand for generic medicines. India is a leader in generic medicines, which are affordable and widely used in both developing and developed countries. The demand for medicines is rising due to ageing populations and an increase in chronic diseases like diabetes and cancer. Another factor is the growth in formulations and vaccines. Indias pharmaceutical exports are not limited to drugs but also include finished formulations, vaccines and biological products. These segments are growing faster due to increased healthcare spending and demand for immunization.

4. Major Export Destinations

Indias pharmaceutical exports are geographically diversified. The top markets for Indias pharmaceutical exports are the United States, Europe and emerging markets like Africa, Latin America and Southeast Asia. The United States accounts for 34% of Indias pharmaceutical exports and is the largest importer of Indian generics. Europe accounts for 19% of Indias pharmaceutical exports.

5. Understanding “Growth in Rupee Terms”

The statement that Indias pharmaceutical exports are likely to grow in terms is important. This means that even if exports do not grow significantly in dollar terms they can still grow in rupee terms due to currency depreciation. For example if the exchange rate changes from ₹80 per dollar to ₹90 per dollar the value of exports in rupees will increase even if the dollar value remains the same. In the context of the year 2026 the Indian rupee has weakened, which increases export earnings in rupee terms.

6. Impact of Rupee Depreciation on Pharmaceutical Exports

The depreciation of the rupee has both negative effects on Indias pharmaceutical exports. The positive effects include earnings for exporters improved profit margins and competitive pricing. The negative effects include an increase in the cost of imports, margin pressure and potential supply disruptions.

7. Challenges Faced by the Pharmaceutical Export Sector

Despite the growth Indias pharmaceutical export sector faces challenges. These include pricing pressure in markets, regulatory issues, dependence on China for active pharmaceutical ingredients, trade policy risks and currency volatility. The sector needs to address these challenges to sustain growth.

8. Comparison with Previous Years

Indias pharmaceutical exports have grown steadily over the years. In the year 2025 exports reached $30.47 billion with a growth rate of 9.4%. In the year 2026 exports have reached $28.29 billion with a growth rate of about 5.6%. While the growth rate has slowed slightly it remains positive.

9. Sector Outlook: Future Growth Potential

Indias sector has strong long-term prospects. The industry is expected to reach $130 billion by 2030 with growth areas including biosimilars, specialty drugs, contract manufacturing and the medical devices sector. The sector is expected to drive growth create employment opportunities and contribute to foreign exchange earnings.

10. Strategic Shifts in Export Markets

India is trying to reduce its over-dependence on the US market. The government is promoting diversification into markets like Africa, Latin America and Southeast Asia. This will reduce the risk from trade barriers and regulatory changes.

11. Role of Innovation and R&D

India traditionally focuses on generics. Future growth depends on innovation, drug discovery and R&D investment. The government is promoting innovation and R&D through initiatives, including the Production Linked Incentive scheme and the Pharma Vision 2030.

12. Government Initiatives Supporting Growth

The government has introduced initiatives to support the growth of the pharmaceutical sector. These include the Production Linked Incentive scheme, bulk drug parks and export promotion councils. These initiatives aim to encourage manufacturing reduce dependence on imports and promote exports.

13. Global Context: Why India is Important

India plays a role in global healthcare by supplying low-cost medicines and helping reduce healthcare costs globally. This is especially important for developing countries and public health programs.

14. Economic Impact on India

Indias pharmaceutical exports contribute to foreign exchange earnings, employment and industrial growth. The sector is a contributor to the countrys economy and has the potential to drive growth in the future.

15. Indias pharmaceutical exports crossing $28 billion till February in the year 2026 highlights the resilience and global importance of the sector. The key takeaways include growth of 5-6% despite global challenges strong demand for generics and vaccines expansion into new markets and likely growth in rupee terms due to currency depreciation. However challenges like pricing pressure API dependence and trade risks must be addressed to sustain growth. The statement reflects a reality. Moderate growth in dollar terms and stronger growth in rupee terms due to currency effects. This shows how exchange rates play a role in export performance especially for globally integrated industries, like pharmaceuticals.